Quick Answer
10x Genomics, Inc. reported Shares Outstanding of 127.69 million shares for fiscal year 2025.
10x Genomics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 127.69M | +4.4% |
| 2024 | 122.29M | +2.7% |
| 2023 | 119.10M | +3.4% |
| 2022 | 115.20M | +2.4% |
| 2021 | 112.51M | +3.7% |
| 2020 | 108.49M | +12.7% |
| 2019 | 96.24M | +561.5% |
| 2018 | 14.55M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| March 31, 2021 | 109.59M | +11.7% | +1.0% |
| December 31, 2020 | 108.49M | +12.7% | +2.7% |
| September 30, 2020 | 105.60M | +9.9% | +5.3% |
| June 30, 2020 | 100.26M | — | +2.2% |
| March 31, 2020 | 98.15M | — | +2.0% |
| December 31, 2019 | 96.24M | +561.5% | +0.1% |
| September 30, 2019 | 96.12M | — | +560.6% |
| December 31, 2018 | 14.55M | — | — |
- 10x Genomics, Inc. showed an increase of +4.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, 10x Genomics, Inc.’s shares outstanding has grown by 777.6% (from 14.55 million shares to 127.69 million shares).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: